20432
document
Prospective randomized controlled trial comparing plasmakinetic vaporesection and conventional transurethral resection of the prostate . OBJECTIVE Plasmakinetic vaporesection of the prostate ( PKVP ) using normal saline irrigation has the theoretical advantage of avoiding transurethral resection syndrome and minimizing blood loss . It may also shorten the operative time since tissue is resected instead of just vaporized . The aim of this study was to evaluate the efficiency , safety and advantages of PKVP compared with standard transurethral resection of the prostate ( TURP ) at a regional acute hospital . METHODS A total of 60 consecutive men admitted from a waiting list for surgery for benign prostatic hyperplasia ( BPH ) were prospectively randomized to either PKVP or TURP . Peri- and postoperative outcome data at 3 months were obtained . RESULTS The PKVP loop achieved a fast and sharp cutting action similar to that with the traditional TURP loop . Data analysis was based on 51 patients . There were no significant differences between the methods in resection time , postoperative catheterization time and hospital stay . The mean reductions in serum sodium 2 hours after PKVP and on postoperative day 1 were 0.52 mmol/L and 3.35 mmol/L , respectively , while mean reductions in haemoglobin were 0.36 g/dL and 0.24 g/dL , respectively . There was no significant difference in haemoglobin reductions between PKVP and TURP ( p = 0.326 at 2 hours ; p = 0.192 on day 1 ) and serum sodium ( p = 0.757 at 2 hours ; p = 0.888 on day 1 ) . Both groups achieved comparable improvement in International Prostate Symptom Score ( p = 0.862 ) , quality-of-life score ( p = 0.169 ) and peak flow rate ( p = 0.96 ) at 3-month follow-up . CONCLUSION PKVP achieved comparable results to traditional TURP and was an effective and safe procedure . However , it did not demonstrate obvious advantages over TURP in this acute regional hospital regular TURP list setting .
20433
Intervention_Surgical
plasmakinetic vaporesection
20434
Intervention_Physical
conventional transurethral resection
20435
Intervention_Surgical
Plasmakinetic vaporesection of the prostate ( PKVP )
20436
Intervention_Surgical
standard transurethral resection of the prostate ( TURP )
20437
Intervention_Surgical
PKVP
20438
Intervention_Physical
TURP
20439
Intervention_Surgical
PKVP
20440
Intervention_Pharmacological
TURP
20441
Outcome_Other
efficiency
20442
Outcome_Other
safety
20443
Outcome_Other
advantages
20444
Outcome_Other
resection time
20445
Outcome_Other
postoperative catheterization time
20446
Outcome_Other
hospital stay
20447
Outcome_Physical
mean reductions in serum sodium
20448
Outcome_Physical
haemoglobin reductions
20449
Outcome_Other
International Prostate Symptom Score
20450
Outcome_Other
effective and safe
20451
Participant_Sample-size
60
20452
Participant_Sex
men
20453
Participant_Condition
benign prostatic hyperplasia ( BPH )
20454
Participant_Sample-size
51 patients